Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Cilloni

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Annals of the New York Academy of Sciences|January 15, 2005
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemiaGiuseppe Saglio, Alessandro Morotti, Giovanna Mattioli, et al.
British Journal of Haematology|September 8, 2006
JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disordersDavide Rossi, Clara Deambrogi, Daniela Capello, et al.
Pediatric Hematology and Oncology|April 22, 2009
Hypereosinophilic syndrome in childhood: clinical and molecular features of two casesPiero Farruggia, Paolo D'Angelo, Antonio Acquaviva, et al.
International Journal of Hematology|September 17, 2009
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcomaPaolo Nicoli, Ubaldo Familiari, Marco Bosa, et al.
Oncotarget|August 27, 2016
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive LeukemiasGiovanna Carrà, Davide Torti, Sabrina Crivellaro, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib doseMassimo Breccia, Daniela Cilloni, Laura Cannella, et al.
British Journal of Haematology|April 4, 2017
Clonal haematopoiesis is not prevalent in survivors of childhood cancerGrace Collord, Naomi Park, Marina Podestà, et al.
Aging Clinical and Experimental Research|April 24, 2020
Impact of kidney transplant morbidity on elderly recipients' outcomesRiccardo Pravisani, Miriam Isola, Umberto Baccarani, et al.
Leukemia Research|February 7, 2018
Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemiaJessica Petiti, Valentina Rosso, Marco Lo Iacono, et al.
Annals of Hematology|February 5, 2020
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromesValentina Rosso, Jessica Petiti, Matteo Dragani, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Annals of the New York Academy of Sciences|January 15, 2005
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemiaGiuseppe Saglio, Alessandro Morotti, Giovanna Mattioli, et al.
British Journal of Haematology|September 8, 2006
JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disordersDavide Rossi, Clara Deambrogi, Daniela Capello, et al.
Pediatric Hematology and Oncology|April 22, 2009
Hypereosinophilic syndrome in childhood: clinical and molecular features of two casesPiero Farruggia, Paolo D'Angelo, Antonio Acquaviva, et al.
International Journal of Hematology|September 17, 2009
HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcomaPaolo Nicoli, Ubaldo Familiari, Marco Bosa, et al.
Oncotarget|August 27, 2016
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive LeukemiasGiovanna Carrà, Davide Torti, Sabrina Crivellaro, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib doseMassimo Breccia, Daniela Cilloni, Laura Cannella, et al.
British Journal of Haematology|April 4, 2017
Clonal haematopoiesis is not prevalent in survivors of childhood cancerGrace Collord, Naomi Park, Marina Podestà, et al.
Aging Clinical and Experimental Research|April 24, 2020
Impact of kidney transplant morbidity on elderly recipients' outcomesRiccardo Pravisani, Miriam Isola, Umberto Baccarani, et al.
Leukemia Research|February 7, 2018
Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemiaJessica Petiti, Valentina Rosso, Marco Lo Iacono, et al.
Annals of Hematology|February 5, 2020
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromesValentina Rosso, Jessica Petiti, Matteo Dragani, et al.
Pageof 20